FORA Capital’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

FORA Capital’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,411	Closed	-$66K	–	997
2021 Q2	$66K	Buy	+2,411	New	+$47.4K	0.01%	672
2020 Q3	–	Sell	-10,137	Closed	-$182K	–	1104
2020 Q2	$182K	Buy	+10,137	New	+$153K	0.06%	367

FORA Capital's TBIO Position: Q3 2021 in Review

FORA Capital sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 2,411 shares — an estimated $66K sold.

FORA Capital first reported a position in TBIO in Q2 2020 and held it in 2 quarters. The position peaked at $182K in Q2 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

FORA Capital reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
FORA Capital sold 2,411 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $66K.
FORA Capital first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
FORA Capital's Translate Bio, Inc. Common Stock position peaked at $182K in Q2 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.